Ionis to present at upcoming investor conferences

Audio By Carbonatix

CARLSBAD, Calif.--(BUSINESS WIRE)--Feb 19, 2026--

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

• Oppenheimer 36 th Annual Healthcare Life Sciences Virtual Conference on Thursday, February 26, 2026
• TD Cowen 46 th Annual Health Care Conference on Monday, March 2, 2026
• Leerink Global Healthcare Conference on Monday, March 9, 2026
• Barclays 28 th Annual Global Healthcare Conference on Wednesday, March 11, 2026
• Stifel 2026 Virtual CNS Forum on Tuesday, March 17, 2026

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals, Inc.

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has marketed medicines and a leading pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260219233764/en/

CONTACT: Ionis Pharmaceuticals Investor Contact:

D. Wade Walke, Ph.D. –[email protected] – 760-603-2331Ionis Pharmaceuticals Media Contact:

Hayley Soffer –[email protected]– 760-603-4679

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH GENETICS CLINICAL TRIALS RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Ionis Pharmaceuticals, Inc.

Copyright Business Wire 2026.

PUB: 02/19/2026 07:05 AM/DISC: 02/19/2026 07:06 AM

http://www.businesswire.com/news/home/20260219233764/en